Related references
Note: Only part of the references are listed.Validation of the Chinese Version of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease
Tian Xu et al.
FRONTIERS IN NEUROLOGY (2021)
Parkinson's disease
Bastiaan R. Bloem et al.
LANCET (2021)
Challenges in the diagnosis of Parkinson's disease
Eduardo Tolosa et al.
LANCET NEUROLOGY (2021)
Prevalence of Non-Motor Symptoms and Non-Motor Fluctuations in Parkinson's Disease Using the MDS-NMS
Carmen Rodriguez-Blazquez et al.
MOVEMENT DISORDERS CLINICAL PRACTICE (2021)
Frequency of non-motor symptoms and their impact on the quality of life in patients with Parkinson's disease: a prospective descriptive case series
Aydin Gulunay et al.
PSYCHOGERIATRICS (2020)
Impulse control disorders in Parkinson disease: A cross-sectional study in Morocco
H. El Otmani et al.
REVUE NEUROLOGIQUE (2019)
Impulse Control Disorders in Parkinson's Disease
Daniel Weintraub et al.
AMERICAN JOURNAL OF PSYCHIATRY (2019)
Parkinson's Disease
Stephen G. Reich et al.
MEDICAL CLINICS OF NORTH AMERICA (2019)
Impulse control and related disorders in Parkinson's disease
Antonio Pedro Vargas et al.
ARQUIVOS DE NEURO-PSIQUIATRIA (2018)
The Outcome of Dopamine Dysregulation Syndrome in Parkinson's Disease: A Retrospective Postmortem Study
Pedro Barbosa et al.
MOVEMENT DISORDERS CLINICAL PRACTICE (2018)
Dopamine dysregulation syndrome in Parkinson's disease: a systematic review of published cases
Nicola Warren et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2017)
Clinical variables and biomarkers in prediction of cognitive CrossMark impairment in patients with newly diagnosed Parkinson's disease: a cohort study
Anette Schrag et al.
LANCET NEUROLOGY (2017)
Clinical manifestations of nonmotor symptoms in 1021 Japanese Parkinson's disease patients from 35 medical centers
Tetsuya Maeda et al.
PARKINSONISM & RELATED DISORDERS (2017)
Incident impulse control disorder symptoms and dopamine transporter imaging in Parkinson disease
Kara M. Smith et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)
A systematic review of treatments for Impulse Control Disorders and related behaviours in Parkinson's disease
Puja Tanwani et al.
PSYCHIATRY RESEARCH (2015)
Impulse control disorders in Parkinson's disease: decreased striatal dopamine transporter levels
Valerie Voon et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)
Dopamine dysregulation syndrome in Parkinson's disease: from clinical and neuropsychological characterisation to management and long-term outcome
Roberto Cilia et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)
Reduced Dopamine Transporter Binding Predates Impulse Control Disorders in Parkinson's Disease
Chris Vriend et al.
MOVEMENT DISORDERS (2014)
Course of psychiatric symptoms and global cognition in early Parkinson disease
Patricia de la Riva et al.
NEUROLOGY (2014)
Long-term outcome of young onset Parkinson's disease after subthalamic stimulation-A cross-sectional study
Sheng-Tzung Tsai et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2013)
Impulsive compulsive behaviors in Japanese Parkinson's disease patients and utility of the Japanese version of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's disease
Kenichiro Tanaka et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2013)
Potential mechanisms underlying anxiety and depression in Parkinson's disease: Consequences of L-DOPA treatment
Karen L. Eskow Jaunarajs et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2011)
The Parkinson Progression Marker Initiative (PPMI)
Kenneth Marek et al.
PROGRESS IN NEUROBIOLOGY (2011)
Behavioral and neurochemical effects of chronic L-DOPA treatment on nonmotor sequelae in the hemiparkinsonian rat
Karen L. Eskow Jaunarajs et al.
BEHAVIOURAL PHARMACOLOGY (2010)
Reduced dopamine transporter density in the ventral striatum of patients with Parkinson's disease and pathological gambling
Roberto Cilia et al.
NEUROBIOLOGY OF DISEASE (2010)
Serotonergic neurons mediate ectopic release of dopamine induced by L-DOPA in a rat model of Parkinson's disease
Sylvia Navailles et al.
NEUROBIOLOGY OF DISEASE (2010)
The MoCA Well-suited screen for cognitive impairment in Parkinson disease
J. C. Dalrymple-Alford et al.
NEUROLOGY (2010)
Impulse control disorders and dopamine dysregulation syndrome associated with dopamine agonist therapy in Parkinson's disease
Sandro Fenu et al.
BEHAVIOURAL PHARMACOLOGY (2009)
Dopamine Dysregulation Syndrome An Overview of its Epidemiology, Mechanisms and Management
Sean S. O'Sullivan et al.
CNS DRUGS (2009)
Nonmotor symptoms in de novo Parkinson disease before and after dopaminergic treatment
Han-Joon Kim et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2009)
Managing Pathological Gambling in Parkinson's Disease with Enteral Levodopa/Carbidopa Infusions
Willi Gerschlager et al.
MOVEMENT DISORDERS (2009)
Impulsive and Compulsive Behaviors in Parkinson's Disease
Andrew H. Evans et al.
MOVEMENT DISORDERS (2009)
Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale Presentation and Clinimetric Testing Results
Christopher G. Goetz et al.
MOVEMENT DISORDERS (2008)
Factors influencing susceptibility to compulsive dopaminergic drug use in Parkinson disease
AH Evans et al.
NEUROLOGY (2005)
Movement disorder society task force report on the Hoehn and Yahr staging scale: Status and recommendations
CG Goetz et al.
MOVEMENT DISORDERS (2004)
Developmental neurocircuitry of motivation in adolescence: A critical period of addiction vulnerability
RA Chambers et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies
G Giovannoni et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2000)
The effect of long-term levodopa therapy on depression level in de novo patients with Parkinson's disease
C Choi et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2000)
Share Paper
